This case was reported by a consumer and described the occurrence of basal cell carcinoma in a (b)(6) female patient who received breathe right nasal strips (breathe right nasal strips advanced) for an unk drug indication.A physician or other health care professional has not verified this report.Co-suspect medication included breathe right nasal strips extra.On an unk date in 2000, the patient started the advanced and extra variants of breathe right nasal strips.At an unk time after starting the variants of breathe right nasal strips, the patient experienced basal cell carcinoma and application site hemorrhage.This case was assessed as medically serious by gsk.Treatment with the variants of breathe right nasal strips was discontinued.At the time of reporting, the events were unresolved.Consumer has been using breathe right advanced and breathe right extra since the year 2000.She discontinued using breathe right advanced and breathe right extra about a year ago because the area on her left nostril began to bleed, so she went for a biopsy.She has been diagnosed with ae-basal cell carcinoma on her left nostril.Multiple lost codes.
|